Amarin Corp Plc (AMRN)

[Whalatane]

Duke and others . Hikma will not delay ....for the reasons HDG outlined . Please correct me HDG if I misread your post .
They will launch ...probably on a limited basis ...by Nov20 2020 ....to retain their 180 day exclusivity .
This gives them first mover advantage ...and time to expand their EPA supply thru Nippon-Suisan who have the available capacity to produce it for them .

So AMRN will spend the next year burning its cash on DTC ads and an 800 member sales force to build the market and Hikma will say thx guys and take over by end of year 2021

AMRN needs to focus on how they can strip costs out of their Co and make Vascepa more affordable to comply with the cost / benefit analysis Canada , Germany and the others will go by to determine their coverage .

The future is the EU and AMRN needs to reform itself to be profitable in that market
Kiwi